If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Takahiro Maeda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Anti-GPRC5D/CD3 bispecific T-cell-redirecting antibody for the treatment of multiple myeloma

Kodama, T., Kochi, Y., Nakai, W., Mizuno, H., Baba, T., Habu, K., Sawada, N., Tsunoda, H., Shima, T., Miyawaki, K., Kikushige, Y., Mori, Y., Miyamoto, T., Maeda, T. & Akashi, K., 2019, In : Molecular cancer therapeutics. 18, 9, p. 1555-1564 10 p.

Research output: Contribution to journalArticle

  • 7 Citations (Scopus)

    Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer

    Nakano, M., Kikushige, Y., Miyawaki, K., Kunisaki, Y., Mizuno, S., Takenaka, K., Tamura, S., Okumura, Y., Ito, M., Ariyama, H., Kusaba, H., Nakamura, M., Maeda, T., Baba, E. & Akashi, K., Feb 7 2019, In : Oncogene. 38, 6, p. 780-793 14 p.

    Research output: Contribution to journalArticle

  • 18 Citations (Scopus)

    DrugThatGene: Integrative analysis to streamline the identification of druggable genes, pathways and protein complexes from CRISPR screens

    Canver, M. C., Bauer, D. E., Maeda, T. & Pinello, L., Jan 1 2019, In : Bioinformatics. 35, 11, p. 1981-1984 4 p., bty913.

    Research output: Contribution to journalArticle

  • Molecular pathogenesis of disease progression in MLL-rearranged AML

    Kotani, S., Yoda, A., Kon, A., Kataoka, K., Ochi, Y., Shiozawa, Y., Hirsch, C., Takeda, J., Ueno, H., Yoshizato, T., Yoshida, K., Nakagawa, M. M., Nannya, Y., Kakiuchi, N., Yamauchi, T., Aoki, K., Shiraishi, Y., Miyano, S., Maeda, T., Maciejewski, J. P. & 3 others, Takaori-Kondo, A., Ogawa, S. & Makishima, H., Mar 1 2019, In : Leukemia. 33, 3, p. 612-624 13 p.

    Research output: Contribution to journalArticle

  • 6 Citations (Scopus)

    Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation

    Mori, Y., Yoshimoto, G., Yuda, J. I., Hayashi, M., Odawara, J., Kuriyama, T., Sugio, T., Miyawaki, K., Kamezaki, K., Kato, K., Takenaka, K., Iwasaki, H., Maeda, T., Miyamoto, T. & Akashi, K., Jan 2 2019, In : Leukemia and Lymphoma. 60, 1, p. 271-273 3 p.

    Research output: Contribution to journalLetter

    1 Citation (Scopus)